This reduction in NF-KB activity significantly attenuates the inflammatory response induced by interleukin-1β, as well as the degradation of type II collagen and glycosaminoglycans, thereby inhibiting the progression of osteoarthritis (OA) [135]. The gene discussed is NFKB1; the disease is osteoarthritis.